Jazz Pharmaceuticals plc buy The Goldman Sachs Group, Inc.
Start price
03.03.23
/
50%
€137.36
Target price
03.03.24
€199.47
Performance (%)
-19.63%
End price
04.03.24
€110.40
Summary
This prediction ended on 04.03.24 with a price of €110.40. The price of Jazz Pharmaceuticals plc has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -19.63%. The_Goldman_Sachs_Gr has a follow-up prediction for Jazz Pharmaceuticals plc where he still thinks Jazz Pharmaceuticals plc is a Buy. The_Goldman_Sachs_Gr has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Jazz Pharmaceuticals plc | 0.329% | 0.329% | -18.988% |
iShares Core DAX® | 0.805% | 2.118% | 15.587% |
iShares Nasdaq 100 | 1.995% | 4.071% | 28.811% |
iShares Nikkei 225® | 1.264% | -2.374% | 3.374% |
iShares S&P 500 | 1.637% | 2.287% | 24.187% |
Comments by The_Goldman_Sachs_Gr for this prediction
In the thread Jazz Pharmaceuticals plc diskutieren
Jazz Pharmaceuticals plc (NASDAQ: JAZZ) had its price target raised by analysts at The Goldman Sachs Group, Inc. from $190.00 to $212.00. They now have a "buy" rating on the stock.
Ratings data for JAZZ provided by MarketBeat
In the thread Trading Jazz Pharmaceuticals plc
Die von The_Goldman_Sachs_Gr gewählte maximale Laufzeit wurde überschritten
Current prediction by The_Goldman_Sachs_Gr for Jazz Pharmaceuticals plc
Jazz Pharmaceuticals plc
Start price
Target price
Perf. (%)
€98.06
05.06.24
05.06.24
€155.23
05.06.25
05.06.25
-0.41%
06.06.24
06.06.24